Page 159 - book
P. 159
Darou Darman Pars
IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
Type Product Dosage form Strength Indication Status
Nervous system, Quetiapine Fumarate FC tablet 100 Antipsychotic Active
antipsychotics (Quptine®)
Fig extract
Gastrointestinal Herbal Syrup 5 g /30 ml Laxatives Active
(Figitol®)
Fig extract
Gastrointestinal Herbal Syrup 5 g /30 ml Laxatives Active
(Figitol®)
Antitussive and expec- Thyme extract and honey 2.9 g/10
torant (Thymusan®) Herbal Syrup ml Antitussive and expectorant Active
Cardiovascular Apixaban (Apinexa®) Tablet 2.5 mg Anticoagulant Active
Cardiovascular Apixaban (Apinexa®) Tablet 5 mg Anticoagulant Active
Anti diabetes Dapagliflozin (Daxella®) Tablet 5 mg Treatment of type 2 diabetes Active
Anti diabetes Dapagliflozin (Daxella®) Tablet 10 mg Treatment of type 2 diabetes Active
Anti diabetes Empagliflozin (Glysano®) Tablet 10 mg Treatment of type 2 diabetes Active
Anti diabetes Empagliflozin (Glysano®) Tablet 25 mg Treatment of type 2 diabetes Active
Empagliflozin (Lijardin®) 25 mg
Anti diabetes Tablet Treatment of type 2 diabetes Active
Linagliptin 5 mg
Empagliflozin (Lijardin®) 10 mg
Anti diabetes Tablet Treatment of type 2 diabetes Active
Linagliptin 5 mg
Empagliflozin (Glysenmin®) 5 mg
Anti diabetes Tablet Treatment of type 2 diabetes Active
Metformin 1000 mg
Empagliflozin (Glysenmin®) 12.5 mg
Anti diabetes Tablet Treatment of type 2 diabetes Active
Metformin 1000 mg
Empagliflozin (Glysenmin®) 5 mg
Anti diabetes Tablet Treatment of type 2 diabetes Active
Metformin 500 mg
Empagliflozin (Glysenmin®) 12.5 mg
Anti diabetes Tablet Treatment of type 2 diabetes Active
Metformin 500 mg
Anti diabetes Linagliptin (Linosenza®) Tablet 5 mg Treatment of type 2 diabetes Active
Antidots, Antagonists, Sevelamer carbonate Control of hyperphosphatae-
Chelators of Phos- (Bivela®) Tablet 800 mg mia (high blood phosphate Active
phate levels)
158
